A review of the reporting and handling of missing data in cohort studies with repeated assessment of exposure measures

by Karahalios Amalia, Baglietto Laura, Carlin John B, English Dallas R, Simpson Julie A
Published 2012-07-01

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria

by Lindegardh Niklas, Tarning Joel, Duffull Stephen B, Jamsen Kris M, White Nicholas J, Simpson Julie A
Published 2011-07-01

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria

by Jamsen Kris M, Duffull Stephen B, Tarning Joel, Lindegardh Niklas, White Nicholas J, Simpson Julie A
Published 2012-07-01

Towards optimal design of anti-malarial pharmacokinetic studies

by White Nicholas J, Price Ric N, Jamsen Kris M, Simpson Julie A, Lindegardh Niklas, Tarning Joel, Duffull Stephen B
Published 2009-08-01

Population pharmacokinetics of artesunate and amodiaquine in African children

by Ouedraogo Alphonse, Ouedraogo Esperance B, Sirima Sodiomon B, Taylor Walter, Stepniewska Kasia, Gansané Adama, Simpson Julie A, Morgan Caroline C, White Nicholas J, Kiechel Jean-René
Published 2009-08-01

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development

by Zaloumis Sophie, Humberstone Andrew, Charman Susan A, Price Ric N, Moehrle Joerg, Gamo-Benito Javier, McCaw James, Jamsen Kris M, Smith Katherine, Simpson Julie A
Published 2012-08-01